While arrhythmia management is a key therapeutic focus in SCN5A-related DCM with a high burden of ventricular ectopy, cases of DCM without overt arrhythmia or conduction disease have been described. The gene discussed is SCN5A; the disease is familial dilated cardiomyopathy.